News | Proton Therapy | September 26, 2016

IBA and Philips Expanding Collaboration in Adaptive Proton Therapy Planning

Agreement includes joint marketing of proton therapy-related technologies, development of new technologies and new installations across the globe

IBA, Philips, adaptive proton therapy planning, ASTRO 2016, collaboration

September 26, 2016 — IBA (Ion Beam Applications S.A.) and Philips announced that they are stepping up their combined efforts in adaptive proton therapy planning through a new long-term collaboration agreement.

The collaboration between the two companies includes the joint marketing and sales of Philips’ imaging and clinical informatics solutions in oncology and IBA’s proton therapy solutions, and the joint development of new products for image-guided proton therapy and treatment modalities. IBA and Philips share the understanding that adaptive therapy planning is key to meeting this objective. The strategic partners have already secured certified compatibility between Philips’ Pinnacle3 therapy planning software and IBA’s proton therapy solution, and they will now jointly develop next-generation proton therapy planning methods to further increase efficiencies in the patient treatment workflow.

Also a result of the collaboration, more than 30 IBA proton therapy centers are expected to benefit from an enhanced cone beam computed tomography (CBCT) imaging technology. This advanced imaging technology provides the large field-of-view needed for enhanced image guidance during proton therapy procedures. To this end, a new software algorithm with an optimized balance between speed and image quality has been developed by the two long-term partners.

IBA and Philips are currently installing state-of-the-art proton therapy solutions at three compact proton therapy centers in the United Kingdom, one compact center in the Middle East, and one large proton therapy center in India. Depending on the proton therapy center, the installed solution can include IBA’s proton therapy systems, such as the Proteus One and Proteus Plus, and Philips’ imaging and clinical informatics solutions, such as Philips’ Big Bore CT and positron emission tomography (PET)/CT systems and Philips’ Pinnacle3 Treatment Planning System.

For more information:,

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.